Advertisement
Letter to the Editor| Volume 65, ISSUE 3, P220-222, March 2012

Differential expression of T cell immunoglobulin- and mucin-domain-containing molecule-3 (TIM-3) according to activity of Behçet's disease

Published:February 16, 2012DOI:https://doi.org/10.1016/j.jdermsci.2012.01.001
      Behçet's disease (BD) is a systemic chronic inflammatory disorder characterized by recurrent oral aphtha, genital ulcers, uveitis, and skin lesions. The etiology and pathogenesis of BD are unknown; however, many studies show a predominant T helper (TH1)-mediated immune response in BD [
      • Imamura Y.
      • Kurokawa M.S.
      • Yoshikawa H.
      • Nara K.
      • Takada E.
      • Masuda C.
      • et al.
      Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease.
      ]. Recently, a novel cell surface protein, T cell immunoglobulin and mucin domain (TIM), was identified [
      • Kuchroo V.K.
      • Umetsu D.T.
      • DeKruyff R.H.
      • Freeman G.J.
      The TIM gene family: emerging roles in immunity and disease.
      ]. Among three genes (TIM-1, TIM-3 and TIM-4) in humans, TIM-3 was found to be specifically expressed by differentiated TH1 cells [
      • Monney L.
      • Sabatos C.A.
      • Gaglia J.L.
      • Ryu A.
      • Waldner H.
      • Chernova T.
      • et al.
      Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.
      ]. Later TIM-3 expression was demonstrated in other cell populations such as Th17, CD8+ cells, NK cells, NCT cells and monocytes [
      • Nakae S.
      • Iwakura Y.
      • Suto H.
      • Galli S.J.
      Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17.
      ,
      • Liu Y.
      • Shu Q.
      • Gao L.
      • Hou N.
      • Zhao D.
      • Liu X.
      • et al.
      Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity.
      ]. The role of Tim-3 in autoimmune diseases and inflammatory diseases has been accumulated. In vivo blockade of Tim-3 enhanced the onset in an adoptive transfer model of autoimmune diabetes [
      • Sánchez-Fueyo A.
      • Tian J.
      • Picarella D.
      • Domenig C.
      • Zheng X.X.
      • Sabatos C.A.
      • et al.
      Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.
      ]. In multiple sclerosis, preferential TIM-3 expression on TH1 cells [
      • Khademi M.
      • Illés Z.
      • Gielen A.W.
      • Marta M.
      • Takazawa N.
      • Baecher-Allan C.
      • et al.
      T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis.
      ] is reported. Considering that TH1 immune responses play an important role in the pathogenesis of BD, we wanted to examine the expression of TIM-3 in BD patients and to determine whether TIM-3 expression is correlated with disease activity.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Imamura Y.
        • Kurokawa M.S.
        • Yoshikawa H.
        • Nara K.
        • Takada E.
        • Masuda C.
        • et al.
        Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease.
        Clin Exp Immunol. 2005; 139: 371-378
        • Kuchroo V.K.
        • Umetsu D.T.
        • DeKruyff R.H.
        • Freeman G.J.
        The TIM gene family: emerging roles in immunity and disease.
        Nat Rev Immunol. 2003; 3: 454-462
        • Monney L.
        • Sabatos C.A.
        • Gaglia J.L.
        • Ryu A.
        • Waldner H.
        • Chernova T.
        • et al.
        Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.
        Nature. 2002; 415: 536-541
        • Nakae S.
        • Iwakura Y.
        • Suto H.
        • Galli S.J.
        Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17.
        J Leukoc Biol. 2007; 81: 1258-1268
        • Liu Y.
        • Shu Q.
        • Gao L.
        • Hou N.
        • Zhao D.
        • Liu X.
        • et al.
        Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity.
        Clin Immunol. 2010; 137: 288-295
        • Sánchez-Fueyo A.
        • Tian J.
        • Picarella D.
        • Domenig C.
        • Zheng X.X.
        • Sabatos C.A.
        • et al.
        Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.
        Nat Immunol. 2003; 4: 1093-1101
        • Khademi M.
        • Illés Z.
        • Gielen A.W.
        • Marta M.
        • Takazawa N.
        • Baecher-Allan C.
        • et al.
        T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis.
        J Immunol. 2004; 172: 7169-7176
        • Yang L.
        • Anderson D.E.
        • Kuchroo J.
        • Hafler D.A.
        Lack of TIM-3 immunoregulation in multiple sclerosis.
        J Immunol. 2008; 180: 4409-4414
        • Hastings W.D.
        • Anderson D.E.
        • Kassam N.
        • Koguchi K.
        • Greenfield E.A.
        • Kent S.C.
        • et al.
        TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines.
        Eur J Immunol. 2009; 39: 2492-2501
        • Shim J.
        • Lee E.S.
        • Park S.
        • Bang D.
        • Sohn S.
        CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model.
        Cytotherapy. 2011; https://doi.org/10.3109/14653249.2011.571245